Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer

Cancer

Volumn 89, Issue 12, 2000, Pages 2646-2654

  Triozzi, Pierre L ^a,b   Khurram, Reema ^a   Aldrich, Wayne A ^a   Walker, Michael J ^a   Kim, Julian A ^a   Jaynes, Sean ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Antigen presenting cells; Breast carcinoma; Cancer immunotherepy; Heat shock protein; Melanoma; Tumor infiltrating lymphocytes

Indexed keywords

ALPHA INTERFERON; CD86 ANTIGEN; FAS LIGAND; GLYCOPROTEIN GP 96; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; MESSENGER RNA; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL DEATH; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MELANOMA; METASTASIS; MONOCYTE; NEUTROPHIL; PHLEBOTOMY; PLASMA; PRIORITY JOURNAL; PROGNOSIS; SKIN TUMOR; TUMOR BIOPSY; TUMOR REGRESSION;

EID: 0034672104     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A     Document Type: Article

References (40)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Roles of Langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer
3. S100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis
4. Dendritic cells prevent lymph node metastasis in patients with gastric cancer
5. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival
6. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance
7. Endoscopic intratumoral injection of OK-432 and Langerhans cells in patients with gastric carcinoma
8. Active immunization using dendritic cells mixed with tumor cell inhibits the growth of primary breast cancer
9. Influence of dendritic cells on tumor growth
10. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
11. Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma
12. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
13. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
14. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells
15. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
16. Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages
17. Identification of tumor-reacting lymph node lymphocytes in vivo using radiolabeled monoclonal antibody
18. Tumor rejection antigens of chemically induced sarcomas of inbred mice
19. Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography
20. Human Fas ligand: Gene structure, chromosomal location and species specificity
21. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease
22. Heat shock protein 70-associated peptides elicit specific cancer immunity
23. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
24. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy
25. Immunohistochemical expression of c-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma
26. Expression of heat shock protein 72 in renal cell carcinoma: Possible role and prognostic implications in cancer patients
27. Local therapy with biological agents: Intralesional therapy
28. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells
29. Intralesional interferon-alpha therapy in advanced malignant melanoma
30. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via Ca2+-dependent mechanism
31. Fas ligand (CD95L) B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
32. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
33. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells
34. Biologic effects of the adoptive transfer of cells depleted of monocyte depletion with L-phenylalanine methyl ester
35. Minimal recruitment and activation of dendritic cells within renal cell carcinoma
36. Dendritic cells in antitumor immune responses
37. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
38. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages
39. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients
40. Intralesional sonographically guided injection of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: A pilot study